University of Sussex

15
“Taking Samples”: Historicizing the Biotech Narrative and the Formation of Regulatory Practice (South Korea, and Singapore, early 1960s- present) John DiMoia, Department of History, NUS / Max Planck Institute for the History of Science, 2014-2016 1

Transcript of University of Sussex

“Taking Samples”: Historicizing the

Biotech Narrative and the Formation of

Regulatory Practice (South Korea, and

Singapore, early 1960s-present)John DiMoia, Department

of History, NUS / Max Planck Institute for the History of Science,

2014-20161

Q: What makes a “Biotech” story? (vs US version / Genentech) •*The economic success

narrative (implicit)

•* The recent story (Hwang, post—1997) (or Biopolis, for Singapore)

•*JTC (SG), and state-driven (SK)

2

Looking at these two cases:

• Hoping to suggest much more humble, developmental origins / circumstances

• Hoping to suggest an earlier context for regulatory practice (even if not always a direct link for the biology)

3

I. The Park Chung Hee state and “health” (1961-

1979)

4

5

Anti-parasite campaigns—All secondary, middle, and

high schools: twice annually from 1969

6

New infrastructure: assistance from OTCA /

Japan

7

Crafting new forms of expertise, medical

technicians

8

To reinforce this point—numerous images, posters, campaigns

9

Part II. And for Singapore?

10

The official / sanctioned story

• JTC (Jurong Town Corporation), Philip Yeo

• Strategic Investment since about 2000

• “liberal laws,” good governance, a space apart from Bush-era stem cell line limitations

11

An alternative story?

12

Framing: The blastocysts story? / Human Reproduction—early to mid-1990s

• ART program at National University Hospital

• Establish protocols for handling, storing, working with tissues (embryos)

• Famous “stem-cell like” objects (now recognized as a precursor, even if not the isolation of HESC lines)

Fertilization and early embryology: Isolation and culture of inner cell mass cells from human blastocystsAriff Bongso1, Chui-Yee Fong, Soon-Chye Ng and Shan Ratnam

13

In summary

• Taking samples (practice, national scale)• Changing behaviors (consent, participation, storage and handling of tissues)

• Mobilization (mass campaigns)

• A context for later efforts, when the “real” biotech comes along in late 20th century, early 21st

14

Thanks~

15